31-Aug-2006
Eli Lilly and Company
Eli Lilly and Company chairman and CEO, Sidney Taurel, today made the case for a Japan-US Economic Integration Agreement, and urged private groups to help lay the groundwork for such a free-trade deal. He also expressed optimism regarding a favorable conclusion of the US-Korea negotiations over a free-trade agreement, arguing that "both sides understand the symbolic as well as the practical benefits of what they are trying to accomplish."
23-Aug-2006
Financial Times
The controversy over the impact of bilateral trade agreements on public health poses particular difficulties for the Geneva-based WHO, which is gearing up for the highly political election of a new director-general.
31-Jul-2006
The Hankyoreh
This examines macro-economic issues, intellectual property and patent protections, the potential impact on pharmaceuticals, and other issues at stake in the U.S.-Korea FTA.
17-Jul-2006
The Edge Daily
Malaysia’s generic drug manufacturers might find it more difficult to conduct business if the US’ negotiations for a free trade agreement (FTA) are influenced by the strong US pharmaceutical lobby there.